. 2017 Jun 26;16:123. doi: 10.1186/s12944-017-0509-3

Table 1.

The correlation between clinicopathologic characteristics and HDL_PO in the training cohort

		Number (n = 189)	Low-HDL_PO group (n = 32)	High-HDL_PO group (n = 157)	P value
Sex	Male	163	28	135	0.821^a
	Female	26	4	22	0.821^a
Age	≤50	69	13	56	0.596
	>50	120	19	101	0.596
Tumor number	Single	151	26	125	0.833
	Multiple	38	6	32	0.833
Tumor size	≤5	120	18	102	0.351
	>5	69	14	55	0.351
Tumor encapsulation	None	115	17	98	0.326
	Complete	74	15	59	0.326
Satellite lesions	No	166	27	139	0.524^a
	Yes	23	5	18	0.524^a
Vascular invasion	No	118	17	101	0.321
	Yes	71	15	56	0.321
Tumor grade	I-II	117	14	103	0.020
	III-IV	72	18	54	0.020
Child-Pugh grade	A	178	29	149	0.347^a
	B	11	3	8	0.347^a
BCLC stage	0 + A	138	24	114	0.781
	B + C	51	8	43	0.781
AFP,μg/L	≤400	139	21	118	0.265
	>400	50	11	39	0.265
ALT,μg/L	≤40	178	32	146	0.124^a
	>40	11	0	11	0.124^a
GGT,IU/L	≤54	110	17	93	0.559
	>54	79	15	64
HbsAg	Negative	23	1	22	0.100^a
	Positive	166	31	135
Recurrence	No	100	11	89	0.032
	Yes	89	21	68

Abbreviations: AFP, α-fetoprotein; ALT, alanine aminotransferase; GGT, γ-glutamyl transpeptadase; HBsAg, hepatitis B surface antigen; BCLC, Barcelona Clinic Liver Cancer ^aFisher’s exact test